Health
Common medicines could lead to cancer patients’ deaths – Ballina Shire Advocate
Cancer patients are more likely to die of their disease if they use common antacids bought at the chemist at the same time as immunotherapy treatments.
Cancer patients are more likely to die of their disease if they use common antacids at the same time as immunotherapies a groundbreaking Australian study has found.
Flinders University researchers found bladder cancer patients using antacids called proton pump inhibitors (PPIs) were more likely to have their cancer progress and were less likely to respond to the breakthrough immunotherapy cancer treatment atezolizumab than those not using antacids.
The reason is the antacids change the patient…
-
Noosa News15 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General13 hours agoCrowe toasts talkback titan for platforming ‘voiceless’
-
General14 hours agoSingapore’s world-first sustainable flights tax will see some Australians pay more to travel
-
Noosa News14 hours agoLyka Doggie Date Night at Moonlight Cinema